- Home
- ZNTL vs ZH Comparison
ZNTL vs ZH Comparison
Compare ZNTL & ZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZNTL | ZH |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 307.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | ZH |
|---|---|---|
| Price | $1.34 | $3.34 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $5.87 | N/A |
| AVG Volume (30 Days) | ★ 508.5K | 289.4K |
| Earning Date | 11-10-2025 | 11-25-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | $26,865,000.00 | ★ $416,437,241.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $3.19 |
| 52 Week High | $3.33 | $6.32 |
Technical Indicators
Market Signals| Indicator | ZNTL | ZH |
|---|---|---|
| Relative Strength Index (RSI) | 42.04 | 31.80 |
| Support Level | $1.34 | $3.23 |
| Resistance Level | $1.45 | $3.42 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 14.71 | 19.23 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.